| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC2156 |
| Trial ID | NCT04037566 |
| Disease | Recurrent Adult Acute Lymphocytic Leukemia |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | XYF19 CAR-T cells |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | CRISPR (HPK1) Edited CD19-specific CAR-T Cells (XYF19 CAR-T Cells) for CD19+ Leukemia or Lymphoma. |
| Year | 2019 |
| Country | China |
| Company sponsor | Xijing Hospital |
| Other ID(s) | V2.1 |
| Vector information | |||
|
|||
| Cohort 1 | |||||||||||
|
|||||||||||